The latest cancer drugs news
Browsing: Cancer Drug News
Newly improved method for anti-cancer drug detection: How tiny tumour models could transform drug testing
A team of researchers from Henan University of Science and Technology have introduced a novel…
FDA-mandated CAR-T monitoring period could be halved
In patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL), the two hallmark post-chimeric antigen receptor…
First-in-class breast cancer drug approved
The Institute of Cancer Research, London, UK, welcomes the news that a new targeted breast…
Team marks milestone in progress toward investigational new drug for triple-negative breast cancer
A new compound developed by researchers at MUSC Hollings Cancer Center, USA, shows promise in…
Diabetes drug reduces drug resistance in lung cancer, improving chemotherapy effectiveness
A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients…
More men with advanced prostate cancer could be successfully treated with precision drug olaparib
Scientists have discovered a genetic aberration found in some prostate cancers that could allow more…
Chemo drug may cause significant hearing loss in longtime cancer survivors
An interdisciplinary study led by researchers at the University of South Florida and Indiana University…
FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma
On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp, a…
New survey from NCCN finds cancer drug shortage management remains a moving target
The National Comprehensive Cancer Network® (NCCN®) in the USA is publishing new results for its latest…
Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients
An analysis of data from a randomised clinical trial for patients with stage 3 colon…